NEWS & INSIGHTS
President’s
End-of-Term Report
(Jan. 2024 – Dec. 2025)
Linda S. Klavinskis, PhD
(ISV President 2024-2025)
Professor of Viral Immunology,
Department of Infectious Diseases,
King’s College London
As the 2024–2025 presidential term comes to a close, I am delighted to celebrate a period of remarkable growth, achievement, and global impact for the International Society for Vaccines (ISV), and thank all who were involved in contributing to these successes and to our members who actively engaged in ISVs activities to advance vaccine science worldwide.
It has been a great honour to serve as the President and to work alongside such an inspiring, dedicated, and passionate global community.
My term has been defined by new initiatives, global collaboration, and a shared commitment to excellence, guided by the missions I set out in January 2024 to advance our society and strengthen its global impact. Here’s a snapshot of what we have achieved together:
ISV December Webinar
Recording Now Available!
Vaccines in the Era of Artificial Intelligence.
Rino Rappuoli, Biotecnopolo di Siena Foundation, Italy
December 2025
ISV Paper of the Month
We are pleased to present our December Paper of the Month: “Assessing AI’s cognitive abilities for scientific discovery in the field of systems vaccinology” by Lucie Rodriguez-Coffinet, Dmitri Kazmin & Bali Pulendran, published in Science Immunology.
ISV 2025 Annual Congress Highlights
ISV Annual Congress
Africa Day Satellite Meeting
Africa Day Satellite Meeting Highlights Regional Vaccine Initiatives
A crucial Africa Day Satellite Meeting spotlighted initiatives aimed at strengthening vaccine protection in Africa, for Africa. More info…
ISV 2025 Annual Congress
Bright Sparks and Poster Presenter Awards. Congratulations to all winner!
Bright Sparks in Vaccinology – PhD Oral Presenter Session
Bright Sparks in Vaccinology – ECR Oral Presenter Session
- 1st - Nicholas Tursi, The Wistar Institute, USA
- 2nd – Juan Garcia-Bernalt Diego, Centro de investigación Hospital Universitario 12 de Octubre, Spain
- 3rd – Claire Otero, Weill Cornell Medicine, USA
Poster Presenter PhD Category
- 1st – Raphael Kamng’ona, MRC Unit at LSHTM
- 2nd – Chinedu Anthony Iwu, IMO STATE UNIVERSITY/TEACHING HOSPITAL
- Joint 3rd – Giovanna de Brito Carneiro, Instituto Butantan
- Joint 3rd – Nelisa Makeleni, University of Cape Town
- Joint 3rd – Rhoda Namakula, University of Bergen
- Joint 3rd – Natalie Nel, University of Cape Town
Poster Presenter ECR Category
- 1st - Faiaz Shaik Abdool,Africa Health Research Institute
- 2nd – Trésor Zola Matuvanga, Université de Kinshasa
- Joint 3rd – Christine Bulaon, Baiya Phytopharm Co., Ltd.
- Joint 3rd – Henning Jacobsen, Helmholtz Centre for Infection Research
2025 ISV Congress Awards
The 2025 ISV Congress celebrated the achievements of leading scientists and contributors in the field of vaccines.
Congratulations to all awardees!
2025 ISV Fellow Awards
- Dr Danilo Casimiro, Sanofi, USA
- Professor Baik-Lin Seong, Yonsei University, South Korea
- The ISV Fellow Award recognises exceptional contributions to the field of vaccines. More info…
2025 Stanley Plotkin Lecture
- Dr Linda-Gail Bekker, Desmond Tutu Health Foundation, University of Cape Town, South Africa,
Stanley Plotkin Lecture: Named in honor of vaccine pioneer Dr. Stanley A. Plotkin, this distinguished lecture is a highlight of the ISV Annual Congress. More info…
2025 ISV Paper of the Year Award
- Dr. Alec W. Freyn, Moderna – Awarded for the paper “Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates” published in Cell.
The ISV Paper of the Year Award recognizes research that has made a significant impact in vaccine science. More info…
2025 ISV Distinguished Service Awards
- Dr Margaret Liu, ProTherImmune and Karolinska Institute, USA and Sweden
- Dr Lenny Moise, Seromyx, USA
- Dr Ed Rybicki, University of Cape Town, South Africa
The Distinguished Service Award honors individuals who have made exceptional contributions to ISV’s mission, including leadership, support, or expertise that advances vaccine science. More info…
